In silico insights into the design of novel NR2B-selective NMDA receptor antagonists: QSAR modeling, ADME-toxicity predictions, molecular docking, and molecular dynamics investigationsMohamed El fadili, Menana Elhallaoui, Rachid Bouzammit et al.|BMC Chemistry|2024Cited by 29
Design of novel potent selective survivin inhibitors using 2D-QSAR modeling, molecular docking, molecular dynamics, and ADMET properties of new MX-106 hydroxyquinoline scaffold derivativesMourad Aloui, Menana Elhallaoui, Mohamed El fadili et al.|Heliyon|2024Cited by 10
In silico design of novel pyridazine derivatives as balanced multifunctional agents against Alzheimer’s diseaseMourad Aloui, Elhalaoui Menana, Mohamed El fadili et al.|Scientific Reports|2025Cited by 7
In silico design of novel dihydropteridone derivatives with oxadiazoles as potent inhibitors of MCF-7 breast cancer cellsMourad Aloui, Elhalaoui Menana, Hatem A. Abuelizz et al.|Frontiers in Chemistry|2025Cited by 1